Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Pediatr Blood Cancer ; 50(2): 384-6, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17072858

RESUMO

Conjunctival melanoma (CM) is a highly malignant tumor that derives from melanocytes and is rarely seen in children. This report describes a 6-year-old female diagnosed with CM.


Assuntos
Neoplasias da Túnica Conjuntiva/patologia , Melanoma/patologia , Criança , Neoplasias da Túnica Conjuntiva/diagnóstico , Feminino , Humanos , Melanoma/diagnóstico
2.
Turk J Pediatr ; 50(6): 592-4, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19227427

RESUMO

Methyldopa is known to cause the production of autoantibodies against red blood cells (RBCs), leading to a positive direct antiglobulin test (DAT) and hemolytic anemia. In about 20% of patients taking methyldopa, IgG autoantibodies develop against RBCs. However, most of the patients do not have hemolysis. A small percentage of such DAT-positive patients, about 2% of those taking methyldopa, develop an autoimmune hemolytic anemia (AIHA). The fact that the DAT is positive in the newborn with unconjugated hyperbilirubinemia is considered as an isoimmune hemolytic disease caused by blood group incompatibility. In this article, a newborn with jaundice and positive DAT without hemolysis is reported. Her mother had the history of taking methyldopa in her pregnancy. Thus, when newborns are detected with positive DAT and jaundice, without blood group incompatibility, mothers should be questioned regarding drugs used in their pregnancy.


Assuntos
Anti-Hipertensivos/efeitos adversos , Teste de Coombs , Hiperbilirrubinemia/diagnóstico , Troca Materno-Fetal , Metildopa/efeitos adversos , Anti-Hipertensivos/administração & dosagem , Diagnóstico Diferencial , Feminino , Humanos , Imunoglobulina G/sangue , Recém-Nascido , Metildopa/administração & dosagem , Gravidez
3.
Breast Care (Basel) ; 7(2): 144-146, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22740802

RESUMO

BACKGROUND: This article is concerned with the evaluation of an adolescent breast mass using imaging methods. CASE REPORT: A 14-year-old girl presented with progressive asymmetric enlargement of the left breast. She had felt a breast lump about 4 months earlier, and over the last 2 months it had been growing progressively. Tumor markers, including AFP, CEA, CA15-3, and CA125, were all normal. Ultrasonography showed a hypoechoichyperechoic, solid mass. Magnetic resonance imaging of the breast revealed a well marginated mass with hypointensity on T1-weighted images and mild hyperintensity on T2-weighted images, which showed mild contrast uptake. Biopsy revealed an undifferentiated malignant mesenchymal sarcoma. The patient underwent mastectomy with axillary lymph node sampling. After the operation, she received 3 cycles of chemotherapy and radiotherapy. CONCLUSION: Due to the rarity of breast sarcoma and inadequate imaging methods to establish an exact diagnosis, radiologists and clinicians may misdiagnose and merely follow these tumors. As in our case, the histology of the patient may be the leading factor in the management of these tumors. Even in very young patients, progressively growing breast masses should alert the clinician to check for malignancy verified by biopsy.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa